-
EP3386499
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3386499
| EP3386499 - ANGIOTENSIN-(1-7) ANALOGS AND METHODS RELATING THERETO [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 10.07.2020 Database last updated on 24.08.2024 | |
| Former | Request for examination was made Status updated on 14.09.2018 | ||
| Former | The international publication has been made Status updated on 16.06.2017 | Most recent event Tooltip | 10.07.2020 | Application deemed to be withdrawn | published on 12.08.2020 [2020/33] | Applicant(s) | For all designated states Wake Forest University Health Sciences Medical Center Boulevard Winston-Salem, NC 27157 / US | For all designated states University College Dublin Belfield, Dublin 4 / IE | [2018/42] | Inventor(s) | 01 /
GALLAGHER, Patricia 311 Winderly Court Lewisville North Carolina 27023 / US | 02 /
TALLANT, E. Ann 9290 Wildflower Woods Way Lewisville North Carolina 276023 / US | 03 /
PARADISI, Francesca 8 Ballintyre Meadows Ballinteer Dublin 16 / IE | 04 /
CHAPPELL, Mark C. 401 E. 4th Street Apt. 506 Winston-Salem North Carolina 27601 / US | [2018/42] | Representative(s) | Bond, Christopher William Forresters IP LLP Skygarden Erika-Mann-Strasse 11 80636 München / DE | [2018/42] | Application number, filing date | 16874055.3 | 12.12.2016 | [2018/42] | WO2016US66181 | Priority number, date | US201562266410P | 11.12.2015 Original published format: US 201562266410 P | CA20152914601 | 11.12.2015 Original published format: CA 2914601 | [2018/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017100776 | Date: | 15.06.2017 | Language: | EN | [2017/24] | Type: | A1 Application with search report | No.: | EP3386499 | Date: | 17.10.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.06.2017 takes the place of the publication of the European patent application. | [2018/42] | Search report(s) | International search report - published on: | US | 15.06.2017 | (Supplementary) European search report - dispatched on: | EP | 16.07.2019 | Classification | IPC: | A61K31/337, A61K31/427, A61K31/475, C07K7/06, A61K38/00, A61K45/06, A61P35/00, A61P29/00 | [2019/33] | CPC: |
A61K45/06 (EP);
C07K7/14 (US);
A61P29/00 (EP);
A61P35/00 (EP,US);
C07K7/06 (EP);
A61K38/00 (EP,US)
|
| Former IPC [2018/42] | A61K31/337, A61K31/427, A61K31/475 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/42] | Title | German: | ANGIOTENSIN (1-7)-ANALOGA UND ASSOZIIERTE VERFAHREN | [2018/42] | English: | ANGIOTENSIN-(1-7) ANALOGS AND METHODS RELATING THERETO | [2018/42] | French: | ANALOGUES DE L'ANGIOTENSINE (1-7) ET PROCÉDÉS ASSOCIÉS | [2018/42] | Entry into regional phase | 24.05.2018 | National basic fee paid | 24.05.2018 | Search fee paid | 24.05.2018 | Designation fee(s) paid | 24.05.2018 | Examination fee paid | Examination procedure | 24.05.2018 | Amendment by applicant (claims and/or description) | 24.05.2018 | Examination requested [2018/42] | 24.05.2018 | Date on which the examining division has become responsible | 13.02.2020 | Application deemed to be withdrawn, date of legal effect [2020/33] | 25.03.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2020/33] | Fees paid | Renewal fee | 12.12.2018 | Renewal fee patent year 03 | 13.12.2019 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2014190152 (TARIX PHARMACEUTICALS LTD [US]) [Y] 1-7 * see claims and examples *; | [Y] - LOUWE DE VRIES ET AL, "Oral and pulmonary delivery of thioether-bridged angiotensin-(1-7)", PEPTIDES, AMSTERDAM, NL, (20100501), vol. 31, no. 5, doi:10.1016/j.peptides.2010.02.015, ISSN 0196-9781, pages 893 - 898, XP055555253 [Y] 1-7 * abstract * DOI: http://dx.doi.org/10.1016/j.peptides.2010.02.015 | [XOY] - WESTER ANITA ET AL, "Biological Screening of Angiotensin-(1-7) Analogues incorporating the Non-natural delta-Amino Acid ACCA", AMINO ACIDS (VIENNA), & 14TH INTERNATIONAL CONGRESS ON AMINO ACIDS, PEPTIDES AND PROTEINS; VIENNA, AUSTRIA; AUGUST 03 -07, 2015, (201508), vol. 48, no. 2, page 636 [XO] 1-4,6 * the whole document * [Y] 1-7 | International search | [A]US2015252057 (GUO LEI [CN], et al) [A] 1-5 * entire document *; | [A]US2010137417 (CHAPPELL MARK DONALD [US], et al) [A] 1-5 * entire document *; | [A]US2008167251 (TALLANT E ANN [US], et al) [A] 1-5 * entire document *; | [PA]WO2016138288 (UNIV RICE WILLIAM M [US]) [PA] 1-5 * entire document * | [A] - O'REILLY et al., "Synthesis of a conformationally constrained d-amino acid building block", Amino Acids, (20120801), vol. 44, pages 511 - 518, XP035167633 [A] 1-5 * . entire document * DOI: http://dx.doi.org/10.1007/s00726-012-1362-3 |